WASHINGTON, May 6 (UPI) -- The U.S. Food and Drug Administration said it has approved a new manufacturing facility for the production of seasonal influenza virus vaccines.
BALTIMORE, April 28 (UPI) -- A vaccine that protects against death and serious complications from different strains of influenza is a little closer to reality, U.S. researchers say.
WASHINGTON, Dec. 9 (UPI) -- Adults under age 50 do not appear to have a different immune response to a half-dose of flu vaccine than to a full dose, U.S. researchers say.
GAITHERSBURG, Md., March 20 (UPI) -- A Maryland firm said Thursday that a single dose of bird flu vaccine, plus a patch, was effective in 73 percent of trial subjects.
CAMBRIDGE, Mass., Jan. 3 (UPI) -- U.S. and British researchers are testing a new universal flu vaccine developed to tackle influenza pandemics.
WASHINGTON, Oct. 1 (UPI) -- The U.S. Food and Drug Administration has approved Afluria, an additional seasonal influenza vaccine for people ages 18 and older.
KING OF PRUSSIA, Pa., April 3 (UPI) -- CSL Biotherapies said Tuesday it has applied for U.S. approval for its influenza vaccine in adults.
GAITHERSBURG, Md., May 4 (UPI) -- The federal government has awarded a $170 million contract to MedImmune Inc. of Maryland for a flu vaccine. The five-year contract from the Health and Human Services Department is to develop cell-based seasonal and pandemic vaccines using its proprietary
ATLANTA, Sept. 23 (UPI) -- Only a small number of American children younger than 2 were fully vaccinated against the flu during the last influenza season, a report issued Thursday said.
ROCHESTER, N.Y., Sept. 7 (UPI) -- U.S. doctors favor vaccinating children against influenza, but with reservations, a University of Rochester survey said.
